AzTrials
AzTrials

Climate ChangeNCT06995755

Atlas:Text Messaging Program With Weather Alerts, Local Resources & Insights for Addressing Climate Change

A study testing atlas in people with Climate Change, run by Pro-Change Behavior Systems at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Climate change is an urgent public health threat, and climate-related health risks disproportionately impact vulnerable populations. To date, digital climate change communications have been limited to one-directional, one size-fits all messaging based on a single theoretical approach (i.e., framing). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Climate Change
What is being tested?
atlas
Could I receive a placebo?
No, everyone receives an active treatment
How many people
54 participants
Where
1 siteUnited States
Study dates
25 Jun 2024to 21 Aug 2024
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18 or older
  • Being a little, moderately, very or extremely sure that climate change is happening now

Who cannot join

  • Younger than 18
  • Being not at all sure that climate change is happening now

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Pro-Change Behavior Systems

    Narragansett, Rhode Island, 02882

Other trials in United States

About this study

Official title: Atlas: An Interactive Text Messaging Program Combining Weather Alerts With Hyper-Localized Resources & Actionable Insights for Addressing Climate Change.

Climate change is an urgent public health threat, and climate-related health risks disproportionately impact vulnerable populations. To date, digital climate change communications have been limited to one-directional, one size-fits all messaging based on a single theoretical approach (i.e., framing). This Phase I SBIR explored the acceptability and effects of an innovative solution: atlas - an interactive text messaging program that leverages insights from behavior change science and integrates data from the National Weather Service to engage a broad spectrum of users with varying levels of concern about climate change and tailor the user experience.

atlas 1) provided information on current climate-related and environmental risks (e.g., high temperatures, air quality alerts, asthma triggers etc.) that might adversely affect a user's current health conditions; 2) linked users to local zip-code matched resources to mitigate their specific risk (e.g., cooling centers, hurricane shelters); 3) implemented a full range of best practices in tailored health behavior change communications to personalize ongoing communications regarding the link between human actions and extreme weather based on the user's level of concern about and belief in climate change; and 4) provided customized actionable tips for addressing climate change to promote climate efficacy at the individual, community, and policy/advocacy level based on the user's level of motivation.

Read more

Developed in collaboration with community members, 2 community health experts, and 4 climate change experts, atlas achieved sustained engagement and impact by hyper-personalizing the user experience and seamlessly integrating actionable insights from multiple theories of behavior change and communication frameworks. Extensive end user and expert input ensured atlas was designed for rapid dissemination.

Residents of a city in a New England state (n=54) were recruited to participate in a 30-day pilot test. The primary outcome, response efficacy for taking steps to mitigate climate change, was assessed across individual, collective, and governmental levels from pretest (baseline) to posttest (30-day follow-up). The hypothesis was that the atlas users will have increased response efficacy.

Conditions
Climate Change
Being tested
atlas

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • atlasBehavioural

    A theoretically-grounded, highly individualized text messaging intervention that 1) provided information on current climate-related and environmental risks (e.g., high temperatures, air quality alerts, asthma triggers etc.) that might adversely affect a user's current health conditions; 2) linked users to local zip-code matched resources to mitigate their specific risk (e.g., cooling centers, hurricane shelters); 3) implemented a full range of best practices in tailored health behavior change communications to personalize ongoing communications regarding the link between human actions and extreme weather based on the user's level of concern about and belief in climate change; and 4) provided customized actionable tips for addressing climate change to promote climate efficacy at the individual, community, and policy/advocacy level based on the user's level of motivation.

Study groups in NCT06995755
Study groupRoleWhat they receive
atlas usersExperimentalAll participants were provided with access to the intervention (atlas)
Receives: Behavioral: atlas

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Response Efficacy Scale

    A 3-item measure of response efficacy that assessed individual, community, and governmental/policy level efficacy for mitigating climate change. It is measured using a Likert scale, with total scores ranging from 3 to 15. Higher scores reflect a better outcome.

    Measured: Pretest (baseline) and Posttest (30 day follow-up)

Secondary outcomes (1)
  1. Confidence

    This 3-item scale assesses an individual's confidence level in taking at least one climate friendly action in the next month. Ratings of confidence will be made on a 5-point Likert scale (1=not at all; 5=extremely confident). Raw scores range from a minimum of 3 to a maximum of 15, with higher scores indicating better outcomes.

    Measured: Pretest (baseline) and Posttest (30 day follow-up)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 May 2025
  2. Study start25 Jun 2024
  3. Primary completion21 Aug 2024
  4. Study completion21 Aug 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
54 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06995755
Sponsor's protocol ID
R43ES035344
Status last verified
Jun 2025
First submitted
8 May 2025
Last updated
26 Jun 2025
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: A variety of peer-reviewed publications will emerge from the proposed research. At the conclusion of the study, the data will be de-identified and then made available to those requesting access, provided that they sign an agreement that the data will be used for research purposes only. Pro-Change routinely asks those requesting access to any data to sign such a form.

Questions about this trial

What is this clinical trial studying?

A study testing atlas in people with Climate Change, run by Pro-Change Behavior Systems at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 26 Jun 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Response Efficacy Scale (time frame: Pretest (baseline) and Posttest (30 day follow-up)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in